The Landscape of Currently Enrolling Maintenance Trials in Multiple Myeloma

Maintenance therapies in multiple myeloma improve survival after induction treatment. This study characterizes the strategies for maintenance therapy being employed in currently enrolling clinical trials for patients with multiple myeloma and highlights how high-risk myeloma patients may be assigned...

Descripción completa

Detalles Bibliográficos
Autores principales: Tariq, Syed Maaz, Abdallah, Al-Ola, Goodman, Aaron, Sborov, Douglas, Mohyuddin, Ghulam Rehman, Britt, Alec
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Netherlands 2023
Materias:
Correspondence
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10241733/
https://www.ncbi.nlm.nih.gov/pubmed/37133718
http://dx.doi.org/10.1007/s44228-023-00044-8
_version_ 1785054053391138816
author Tariq, Syed Maaz
Abdallah, Al-Ola
Goodman, Aaron
Sborov, Douglas
Mohyuddin, Ghulam Rehman
Britt, Alec
author_facet Tariq, Syed Maaz
Abdallah, Al-Ola
Goodman, Aaron
Sborov, Douglas
Mohyuddin, Ghulam Rehman
Britt, Alec
author_sort Tariq, Syed Maaz
collection PubMed
description Maintenance therapies in multiple myeloma improve survival after induction treatment. This study characterizes the strategies for maintenance therapy being employed in currently enrolling clinical trials for patients with multiple myeloma and highlights how high-risk myeloma patients may be assigned to maintenance strategies incongruent with current US guidelines.
format Online
Article
Text
id pubmed-10241733
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Springer Netherlands
record_format MEDLINE/PubMed
spelling pubmed-102417332023-06-07 The Landscape of Currently Enrolling Maintenance Trials in Multiple Myeloma Tariq, Syed Maaz Abdallah, Al-Ola Goodman, Aaron Sborov, Douglas Mohyuddin, Ghulam Rehman Britt, Alec Clin Hematol Int Correspondence Maintenance therapies in multiple myeloma improve survival after induction treatment. This study characterizes the strategies for maintenance therapy being employed in currently enrolling clinical trials for patients with multiple myeloma and highlights how high-risk myeloma patients may be assigned to maintenance strategies incongruent with current US guidelines. Springer Netherlands 2023-05-03 /pmc/articles/PMC10241733/ /pubmed/37133718 http://dx.doi.org/10.1007/s44228-023-00044-8 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Correspondence
Tariq, Syed Maaz
Abdallah, Al-Ola
Goodman, Aaron
Sborov, Douglas
Mohyuddin, Ghulam Rehman
Britt, Alec
The Landscape of Currently Enrolling Maintenance Trials in Multiple Myeloma
title The Landscape of Currently Enrolling Maintenance Trials in Multiple Myeloma
title_full The Landscape of Currently Enrolling Maintenance Trials in Multiple Myeloma
title_fullStr The Landscape of Currently Enrolling Maintenance Trials in Multiple Myeloma
title_full_unstemmed The Landscape of Currently Enrolling Maintenance Trials in Multiple Myeloma
title_short The Landscape of Currently Enrolling Maintenance Trials in Multiple Myeloma
title_sort landscape of currently enrolling maintenance trials in multiple myeloma
topic Correspondence
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10241733/
https://www.ncbi.nlm.nih.gov/pubmed/37133718
http://dx.doi.org/10.1007/s44228-023-00044-8
work_keys_str_mv AT tariqsyedmaaz thelandscapeofcurrentlyenrollingmaintenancetrialsinmultiplemyeloma
AT abdallahalola thelandscapeofcurrentlyenrollingmaintenancetrialsinmultiplemyeloma
AT goodmanaaron thelandscapeofcurrentlyenrollingmaintenancetrialsinmultiplemyeloma
AT sborovdouglas thelandscapeofcurrentlyenrollingmaintenancetrialsinmultiplemyeloma
AT mohyuddinghulamrehman thelandscapeofcurrentlyenrollingmaintenancetrialsinmultiplemyeloma
AT brittalec thelandscapeofcurrentlyenrollingmaintenancetrialsinmultiplemyeloma
AT tariqsyedmaaz landscapeofcurrentlyenrollingmaintenancetrialsinmultiplemyeloma
AT abdallahalola landscapeofcurrentlyenrollingmaintenancetrialsinmultiplemyeloma
AT goodmanaaron landscapeofcurrentlyenrollingmaintenancetrialsinmultiplemyeloma
AT sborovdouglas landscapeofcurrentlyenrollingmaintenancetrialsinmultiplemyeloma
AT mohyuddinghulamrehman landscapeofcurrentlyenrollingmaintenancetrialsinmultiplemyeloma
AT brittalec landscapeofcurrentlyenrollingmaintenancetrialsinmultiplemyeloma

Ejemplares similares